Newshour - Mark Zuckerberg defends Instagram

The owner of Instagram and Facebook has been testifying in a landmark legal case over social media addiction, which could pave the way for future hearings.

Also on the programme: Les Wexner, who gave Jeffrey Epstein his own fortune to manage and who was pivotal in his rise as a financier, has told a Congressional inquiry he was naive and was duped, but not himself involved in sexual abuse. And the widow of the Hollywood actor Chadwick Boseman tells us about the revival of "Deep Azure," a play he wrote twenty years ago, in London.

(Picture: Mark Zuckerberg arrives in court. Credit: Reuters)

WSJ What’s News - The Seattle Seahawks, Super Bowl Winners, Go Up for Sale

P.M. Edition for Feb. 18. A long-anticipated sale of the Seattle Seahawks is now underway—and the sale price could break NFL records. Plus, Stephen Hemsley, the leader of UnitedHealth Group, for years made private investments in healthcare startups. Journal senior editor Mark Maremont digs into how some of those companies also did business with, or competed against, UnitedHealth. And in his testimony at a landmark social media trial, Meta CEO Mark Zuckerberg defended the company’s practices. Alex Ossola hosts.


Sign up for the WSJ's free What's News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Motley Fool Money - Warren Buffett’s Last Hurrah

We got the final filing of Berkshire Hathaway’s stock holdings this week and it once again showed Warren Buffett selling tech stocks to buy consumer goods companies. Then we discussed Netflix’s latest saga buying Warner Bros. Discovery and why homebuilders are building fewer homes.


Travis Hoium, Lou Whiteman, and Rachel Warren discuss:


- Buffet’s final stock buys

- Netflix gives Paramount one more shot

- Homebuilder trends


Companies discussed: Toll Brothers (TOL), Apple (AAPL), Netflix (NFLX), Warner Bros. Discovery (WBD).


Host: Travis Hoium

Guests: Lou Whiteman, Rachel Warren

Engineer: Dan Boyd, Kristi Waterworth


Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement.


We’re committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode.


Learn more about your ad choices. Visit ⁠megaphone.fm/adchoices⁠

Learn more about your ad choices. Visit megaphone.fm/adchoices

WSJ Minute Briefing - Stocks Rise on Strength of Chip Shares

Plus: Nvidia shares rise after announcing a deal with Meta. And Moderna stock jumps as FDA does a U-turn on its new flu vaccine. Katherine Sullivan hosts.


Sign up for the WSJ's free What's News newsletter.


An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.

Learn more about your ad choices. Visit megaphone.fm/adchoices

WSJ Your Money Briefing - What’s Actually Happening in the U.S. Jobs Market?

This week, we feature an episode of What’s News Sunday exploring the deepening contradictions in the U.S. labor market. While corporate downsizing and AI integration drove January layoffs to their highest levels since 2009, official reports still show job gains. Host Luke Vargas examines why recent data revisions are leading workers and employers alike to question the reliability of hiring figures. Plus, WSJ reporters Justin Lahart and Lindsay Ellis break down listener questions on the reality of the current hiring climate.


Further Reading

What Sweeping Revisions and a Blowout Month Tell Us About the U.S. Job Market

Job Growth Last Year Was Far Worse Than We Thought. Here’s Why.

This Is Why It’s So Hard to Find a Job Right Now

America’s Job Market Has Entered the Slow Lane

Job Hunters Are So Desperate That They’re Paying to Get Recruited

CEOs Say AI Is Making Work More Efficient. Employees Tell a Different Story.

Five Older Job Seekers Tell Us How They Broke Through a Bruising Job Market

Learn more about your ad choices. Visit megaphone.fm/adchoices

Planet Money - How to get what Greenland has, with permission

Book tour and ticket info here.


Greenland has said it is not for sale. Denmark has said it can’t even legally sell Greenland. And at a security conference in Munich over the weekend, U.S. lawmakers spent a lot of time trying to walk back some of President Trump’s recent threats to try to buy, or even take over, the territory. 

But whether Trump can or will or should try to control or purchase a territory that doesn’t want to be sold is not the interesting question. What is interesting is how we got to this moment. And, how we might gracefully get out of it. 

Greenland is valuable for its minerals and because of its physical location in the world. (It’s easy to keep an eye on other countries from Greenland).

Our latest: How the U.S. dropped the ball on the rare earths race. And one way the U.S. gets strategic locations without threatening to buy or take over an entire territory.


Further listening: 

- Is Greenland really an untapped land of riches?

- Add to cart: Greenland


Pre-order the Planet Money book and get a free gift. / Subscribe to Planet Money+

Listen free: Apple Podcasts, Spotify, the NPR app or anywhere you get podcasts.

Facebook / Instagram / TikTok / Our weekly Newsletter.

This episode was produced by Willa Rubin with help from Sam Yellowhorse Kesler. It was edited by Marianne McCune. Fact-checking help from Sierra Juarez. It was engineered by Kwesi Lee and Robert Rodriguez. Alex Goldmark is our executive producer.

Music: Universal Music Production - "The Attraction,” “Carnivore,” and “Walls Come Out.”

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

The Journal. - The Flu Shot Drama at the FDA

The Food and Drug Administration agreed to begin a review of biotech company Moderna’s application to make a new seasonal flu shot available. The decision comes after the FDA initially refused to review the company's application. It's a back and forth that reveals increased turmoil within the agency. WSJ’s Liz Essley Whyte takes us inside the FDA’s unexpected reversals and explores what’s next for the mRNA flu vaccine. Jessica Mendoza hosts. 


Further Listening:

- The FDA Commissioner on Vaccines and Public Trust

- Breakfast Battle: The Cereal Industry vs MAHA


Sign up for WSJ’s free What’s News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The Bulwark Podcast - Mark Leibovich: Democrats Are Too Afraid of Hurting People’s Feelings

Most Democratic politicians are scared to criticize each other. They also fear dinging former presidents, or the various groups that make up the party’s broad coalition. And too many Dem candidates are afraid to color outside the lines, even if voters want them to be less establishment and more like regular people. Can the party get it together before the midterms? Plus, Trump’s threat of war against Iran, and his reported intent to kill Netflix’s bid to takeover Warner Discovery—potentially giving him power over CBS, CNN, Fox, and TikTok.

The Atlantic’s Mark Leibovich joins Tim Miller.

show notes